2024 Q2 Form 10-Q Financial Statement

#000162828024022915 Filed on May 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $20.70M $14.75M $21.00M
YoY Change 58.15% 37.39% 75.03%
Cost Of Revenue $10.45M $8.203M $11.13M
YoY Change 33.0% 24.61% 29.44%
Gross Profit $10.25M $6.547M $9.872M
YoY Change 95.91% 57.65% 190.35%
Gross Profit Margin 49.53% 44.39% 47.0%
Selling, General & Admin $10.14M $9.946M $10.67M
YoY Change 10.22% -18.6% -45.3%
% of Gross Profit 98.93% 151.92% 108.04%
Research & Development $2.354M $2.347M $2.288M
YoY Change -14.24% -18.79% -49.16%
% of Gross Profit 22.96% 35.85% 23.18%
Depreciation & Amortization $104.0K $109.0K $136.0K
YoY Change -56.12% -62.8% -61.8%
% of Gross Profit 1.01% 1.66% 1.38%
Operating Expenses $12.50M $12.29M $12.95M
YoY Change 4.6% -18.64% -46.25%
Operating Profit -$2.244M -$5.746M -$3.082M
YoY Change -66.58% -47.55% -85.11%
Interest Expense -$20.00K $161.0K -$193.0K
YoY Change -138.46% -94.27% -35.67%
% of Operating Profit
Other Income/Expense, Net $1.119M $9.020M -$3.646M
YoY Change -164.02% -1090.12% -343.07%
Pretax Income -$1.125M $3.274M -$6.921M
YoY Change -86.71% -127.59% -64.51%
Income Tax $22.00K $0.00 $5.000K
% Of Pretax Income 0.0%
Net Earnings -$1.147M $3.274M -$8.219M
YoY Change -86.45% -127.59% -57.85%
Net Earnings / Revenue -5.54% 22.2% -39.13%
Basic Earnings Per Share -$0.30 $0.15
Diluted Earnings Per Share -$0.30 -$0.51 -$0.97
COMMON SHARES
Basic Shares Outstanding 9.048M shares 8.964M shares 8.569M shares
Diluted Shares Outstanding 8.867M shares 9.618M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.36M $18.40M $16.56M
YoY Change -37.92% -25.71% 47.83%
Cash & Equivalents $15.36M $18.40M $16.56M
Short-Term Investments
Other Short-Term Assets $2.171M $2.288M $2.921M
YoY Change 32.95% -53.84% -47.84%
Inventory $8.101M $7.738M $6.493M
Prepaid Expenses
Receivables $16.90M $11.60M $13.97M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $42.53M $40.02M $39.94M
YoY Change -17.81% -33.15% -22.14%
LONG-TERM ASSETS
Property, Plant & Equipment $193.0K $284.0K $377.0K
YoY Change -68.31% -65.95% -88.91%
Goodwill
YoY Change
Intangibles $2.224M $2.209M $2.210M
YoY Change -1.29% -2.69% -3.03%
Long-Term Investments
YoY Change
Other Assets $731.0K $733.0K $655.0K
YoY Change -28.12% -29.18% -40.45%
Total Long-Term Assets $3.365M $3.807M $4.179M
YoY Change -39.02% -37.25% -38.54%
TOTAL ASSETS
Total Short-Term Assets $42.53M $40.02M $39.94M
Total Long-Term Assets $3.365M $3.807M $4.179M
Total Assets $45.90M $43.83M $44.12M
YoY Change -19.85% -33.52% -24.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.51M $16.06M $13.68M
YoY Change -23.06% -47.91% -55.0%
Accrued Expenses $11.55M $11.00M $15.05M
YoY Change 3.08% -21.62% -24.75%
Deferred Revenue $1.242M $1.144M $1.166M
YoY Change 19.88% 9.79% 1.57%
Short-Term Debt $9.738M $7.212M $9.250M
YoY Change 19.1% 96.81%
Long-Term Debt Due $2.110M $4.032M $5.944M
YoY Change -59.45% -15.96% -42.85%
Total Short-Term Liabilities $42.15M $39.46M $45.09M
YoY Change -12.88% -22.21% -32.3%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $150.0K $705.0K $906.0K
YoY Change -91.52% -64.87% -56.86%
Total Long-Term Liabilities $150.0K $705.0K $906.0K
YoY Change -96.02% -87.2% -56.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $42.15M $39.46M $45.09M
Total Long-Term Liabilities $150.0K $705.0K $906.0K
Total Liabilities $66.73M $65.62M $73.80M
YoY Change -15.52% -19.87% 7.42%
SHAREHOLDERS EQUITY
Retained Earnings -$253.5M -$252.4M -$255.7M
YoY Change 4.29% 7.57% 14.77%
Common Stock $1.000K $1.000K $1.000K
YoY Change 0.0% -91.67% -91.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$33.43M -$32.93M -$37.53M
YoY Change
Total Liabilities & Shareholders Equity $45.90M $43.83M $44.12M
YoY Change -19.85% -33.52% -24.06%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$1.147M $3.274M -$8.219M
YoY Change -86.45% -127.59% -57.85%
Depreciation, Depletion And Amortization $104.0K $109.0K $136.0K
YoY Change -56.12% -62.8% -61.8%
Cash From Operating Activities -$3.335M -$3.339M -$1.576M
YoY Change -54.83% -64.38% -83.96%
INVESTING ACTIVITIES
Capital Expenditures $67.00K $0.00 $29.00K
YoY Change 509.09% -100.0% -82.1%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$67.00K -$54.00K -$29.00K
YoY Change 509.09% 575.0% -82.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $1.500M
YoY Change 0.0%
Cash From Financing Activities 368.0K $5.233M 2.997M
YoY Change -95.01% -77.16% -253.22%
NET CHANGE
Cash From Operating Activities -3.335M -$3.339M -1.576M
Cash From Investing Activities -67.00K -$54.00K -29.00K
Cash From Financing Activities 368.0K $5.233M 2.997M
Net Change In Cash -3.034M $1.840M 1.392M
YoY Change 15868.42% -86.4% -111.66%
FREE CASH FLOW
Cash From Operating Activities -$3.335M -$3.339M -$1.576M
Capital Expenditures $67.00K $0.00 $29.00K
Free Cash Flow -$3.402M -$3.339M -$1.605M
YoY Change -53.99% -64.4% -83.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8110387 shares
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
280000 usd
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.071
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11596000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13973000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
7738000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
6493000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2288000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2921000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
40019000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
39944000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
284000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
377000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
581000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
937000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2209000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2210000 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
733000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
655000 usd
CY2024Q1 us-gaap Assets
Assets
43826000 usd
CY2023Q4 us-gaap Assets
Assets
44123000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
16064000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13679000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11003000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15051000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1144000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1166000 usd
CY2024Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
7212000 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
9250000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
4032000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5944000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
39455000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
45090000 usd
CY2024Q1 owlt Common Stock Warrant Liability
CommonStockWarrantLiability
25457000 usd
CY2023Q4 owlt Common Stock Warrant Liability
CommonStockWarrantLiability
27781000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
705000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
928000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
65617000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
73799000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
107142857 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
107142857 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9014403 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9014403 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
219450000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
218127000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-252385000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-255659000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-32934000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-37531000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43826000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44123000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14750000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10736000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8203000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6583000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
6547000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
4153000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6050000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8866000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3896000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3353000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2347000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2890000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
12293000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
15109000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5746000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10956000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
161000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
2812000 usd
CY2024Q1 owlt Change In Fair Value Of Common Stock Warrantliability
ChangeInFairValueOfCommonStockWarrantliability
-9179000 usd
CY2023Q1 owlt Change In Fair Value Of Common Stock Warrantliability
ChangeInFairValueOfCommonStockWarrantliability
-1912000 usd
CY2024Q1 owlt Other Income Expense Net
OtherIncomeExpenseNet
2000 usd
CY2023Q1 owlt Other Income Expense Net
OtherIncomeExpenseNet
-11000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9020000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-911000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3274000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11867000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
3274000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11867000 usd
CY2024Q1 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
1328000 usd
CY2023Q1 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
653000 usd
CY2024Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-661000 usd
CY2023Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1285000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12520000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.54
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.51
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.54
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8740059 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9617825 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8110387 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-10635000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
43000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
55000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
101000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2789000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-20167000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-37531000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
0 usd
CY2024Q1 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
332000 shares
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
92000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2227000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
3274000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-32934000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
3274000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11867000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
109000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
293000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2227000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2789000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-388000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
83000 usd
CY2024Q1 owlt Change In Fair Value Of Common Stock Warrantliability
ChangeInFairValueOfCommonStockWarrantliability
-9179000 usd
CY2023Q1 owlt Change In Fair Value Of Common Stock Warrantliability
ChangeInFairValueOfCommonStockWarrantliability
-1912000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
356000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
332000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-25000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-94000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2765000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-480000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-555000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1261000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1245000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3771000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1158000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5661000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
680000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-963000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3339000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9374000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6000 usd
CY2024Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
54000 usd
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-54000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8000 usd
CY2024Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
158000 usd
CY2023Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
9092000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
30000000 usd
CY2024Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
28941000 usd
CY2023Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
32895000 usd
CY2024Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
31392000 usd
CY2023Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
38635000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1500000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1500000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
92000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
156000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5233000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22916000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1840000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13534000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16557000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11231000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18397000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24765000 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
107142857 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-252385000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3339000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9374000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18397000 usd
CY2024Q1 owlt Proceeds From Issuance Of Convertible Preferred Stock Gross
ProceedsFromIssuanceOfConvertiblePreferredStockGross
30000000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
9250000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 usd
CY2024Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
7253000 usd
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
7212000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3013000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
83000 usd
CY2023Q1 owlt Accounts Receivable Allowance For Doubtful Accounts Charges To Revenue
AccountsReceivableAllowanceForDoubtfulAccountsChargesToRevenue
20000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
128000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2948000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3322000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-388000 usd
CY2024Q1 owlt Accounts Receivable Allowance For Doubtful Accounts Charges To Revenue
AccountsReceivableAllowanceForDoubtfulAccountsChargesToRevenue
-56000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
2490000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
500000 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3742000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3760000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3458000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3383000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
284000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
377000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2209000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
296000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2210000 usd
CY2023Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
1873000 usd
CY2024Q1 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
1873000 usd
CY2024Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
0 usd
CY2023Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
0 usd
CY2024Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2023Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2024Q1 owlt Accrued Sales Return Current
AccruedSalesReturnCurrent
1281000 usd
CY2023Q4 owlt Accrued Sales Return Current
AccruedSalesReturnCurrent
2919000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
4032000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5944000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
782000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
712000 usd
CY2024Q1 owlt Provision For Warranties Issued During The Period
ProvisionForWarrantiesIssuedDuringThePeriod
177000 usd
CY2023Q1 owlt Provision For Warranties Issued During The Period
ProvisionForWarrantiesIssuedDuringThePeriod
35000 usd
CY2024Q1 owlt Settlements Of Warranty Claims During The Period
SettlementsOfWarrantyClaimsDuringThePeriod
191000 usd
CY2023Q1 owlt Settlements Of Warranty Claims During The Period
SettlementsOfWarrantyClaimsDuringThePeriod
155000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
768000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
592000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1302000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1386000 usd
CY2024Q1 owlt Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
521000 usd
CY2023Q1 owlt Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
395000 usd
CY2024Q1 owlt Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
543000 usd
CY2023Q1 owlt Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
524000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1280000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1257000 usd
CY2024Q1 owlt Contract With Customer Liability Revenue Recognized Excluding Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance
477000 usd
CY2023Q1 owlt Contract With Customer Liability Revenue Recognized Excluding Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance
483000 usd
CY2024Q1 owlt Contract With Customer Liability Revenue Recognized Related To Correction Of An Error Excluding Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedRelatedToCorrectionOfAnErrorExcludingOpeningBalance
330000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
4032000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
5944000 usd
CY2024Q1 owlt Long Term Debt Future Aggregate Maturity Remainder Of Fiscal Year
LongTermDebtFutureAggregateMaturityRemainderOfFiscalYear
4032000 usd
CY2024Q1 owlt Long Term Debt Future Aggregate Maturity Total
LongTermDebtFutureAggregateMaturityTotal
4032000 usd
CY2023Q1 owlt Related Party Transaction Monthly Interest Payment To Related Party
RelatedPartyTransactionMonthlyInterestPaymentToRelatedParty
3000000 usd
CY2023Q1 owlt Related Party Transaction Monthly Interest Payment To Related Party Payment Period
RelatedPartyTransactionMonthlyInterestPaymentToRelatedPartyPaymentPeriod
P36M
CY2021Q4 us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
2 claim
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2227000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2789000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
717000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
102000 usd
CY2020Q3 owlt Period Required For Warrants To Become Exercisable Initial Public Offering
PeriodRequiredForWarrantsToBecomeExercisableInitialPublicOffering
P12M
CY2024Q1 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
9175282 shares
CY2024Q1 owlt Class Of Warrant Or Right Warrants Issued During Period
ClassOfWarrantOrRightWarrantsIssuedDuringPeriod
1799021 shares
CY2024Q1 owlt Class Of Warrant Or Right Warrants Exercised During Period
ClassOfWarrantOrRightWarrantsExercisedDuringPeriod
0 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10974303 shares
CY2024Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
17917000 usd
CY2024Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
25457000 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
16489000 usd
CY2023Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
27781000 usd
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
27781000 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
6855000 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-9179000 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
25457000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
3274000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11867000 usd
CY2024Q1 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
1328000 usd
CY2023Q1 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
653000 usd
CY2024Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-661000 usd
CY2023Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1285000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12520000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8740059 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8110387 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.54
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
3274000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11867000 usd
CY2024Q1 us-gaap Dilutive Securities
DilutiveSecurities
-6809000 usd
CY2023Q1 us-gaap Dilutive Securities
DilutiveSecurities
0 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-4863000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-12520000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8740059 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8110387 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
877766 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9617825 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8110387 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.51
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.54
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10383704 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14555009 shares
CY2024Q1 owlt Common Stock Shares Subject To Vesting
CommonStockSharesSubjectToVesting
200536 shares
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14750000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10736000 usd
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
865000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
1314000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-24-022915-index-headers.html Edgar Link pending
0001628280-24-022915-index.html Edgar Link pending
0001628280-24-022915.txt Edgar Link pending
0001628280-24-022915-xbrl.zip Edgar Link pending
ex-103_waiverxagreementxxx.htm Edgar Link pending
ex-311owletinc302certifica.htm Edgar Link pending
ex-312owletinc302certifica.htm Edgar Link pending
ex-321owletinc906certifica.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_2.jpg Edgar Link pending
image_3.jpg Edgar Link pending
image_4.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
owlt-20240331.htm Edgar Link pending
owlt-20240331.xsd Edgar Link pending
owlt-20240331_g1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
owlt-20240331_cal.xml Edgar Link unprocessable
owlt-20240331_def.xml Edgar Link unprocessable
owlt-20240331_lab.xml Edgar Link unprocessable
owlt-20240331_pre.xml Edgar Link unprocessable
owlt-20240331_htm.xml Edgar Link completed
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable